A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
6/19/2026
BreakingChinaDealsRefractiveSurgical
Aier Eye Hospital Group to Buy 25 VisuMax 800 Lasers from Zeiss
German company Carl Zeiss Meditec reported June 17 that the Aier Eye Hospital Group in China had agreed to buy 25 VisuMax 800 femtosecond lasers for its hospital locations starting this year. The V...
6/19/2026
BreakingIndustry
Johnson & Johnson to Invest $1 Billion in Jacksonville, Home of J&J Vision
Johnson & Johnson reported June 15 that it would invest more than $1 billion in its Jacksonville, Florida, operations to scale US-based manufacturing, packaging, and distribution capabilities for i...
6/19/2026
BreakingPharmaRegulationRetina
Belite Bio Completes Rolling NDA Submission for Oral Tinlarebant in Stargardt
Belite Bio announced June 12 that it had completed its rolling new drug application (NDA) submission to the US FDA for oral tinlarebant for the treatment of Stargardt disease. The San Diego, Califo...
6/18/2026
MeetingNewsletterRetina
2026 ARVO Meeting Draws Big Attendance, Rare Snowstorm
The 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) drew 10,996 attendees, the second largest attendance to date, coming in just under the 2024 total of 11,631. The ...
6/19/2026
BreakingCataractIOLSurgical
J&J Expands US Rollout of Tecnis PureSee IOL
Johnson & Johnson reported June 11 that it was expanding availability for the Tecnis PureSee IOL in the US. The lens gained US FDA approval in March 2026. The PureSee is a purely refractive extende...
6/19/2026
BreakingCataractEquipmentSurgical
Alcon Launches Unity CS Phaco System in Canada
Alcon announced June 15 the launch in Canada of the Unity CS phacoemulsification system for cataract surgery. Alcon said it planned to showcase the platform at the Canadian Ophthalmological Society...
6/19/2026
BreakingGlaucomaIndustryPharmaRetina
Tavo Biotherapeutics Appoints Federico Grossi, MD, PhD, as CMO
Tavo Biotherapeutics, of Laguna Beach, California, announced June 2 that it had appointed Federico Grossi, MD, PhD, as chief medical officer (CMO). Grossi most recently was CMO of Unity Biotechnolo...
6/19/2026
BreakingCornealDry EyeRegulation
TearSolutions Gains Orphan, Fast Track Status for Lacripep in Neurotrophic Keratitis
TearSolutions announced June 2 that the US FDA had granted orphan drug and fast track designations for its synthetic peptide eye drop candidate Lacripep in neurotrophic keratitis (NK). NK is a rare...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.